Cargando…

Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis

BACKGROUND: Relapse is a problem in patients with Crohn’s disease (CD) after medical therapy (including biologics) and after surgery to treat acute inflammation. It is unclear whether the recurrence rate over time is higher after surgical therapy than after continuous drug treatment. AIM: We sought...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kneißl, Sarah, Stallhofer, Johannes, Schlattmann, Peter, Stallmach, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560971/ https://www.ncbi.nlm.nih.gov/pubmed/36149447 http://dx.doi.org/10.1007/s00384-022-04254-z

Ejemplares similares

Correction to: Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis
por: Kneißl, Sarah, et al.
Publicado: (2022)

Meta-analysis of aspirin-guided therapy of colorectal cancer
por: Mädge, Johanna C., et al.
Publicado: (2022)

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease
por: Stallhofer, Johannes, et al.
Publicado: (2023)

What are the predictors for recurrence of Crohn's disease after surgery?
por: Ozgur, Ilker, et al.
Publicado: (2021)

Laparoscopic Surgery for Recurrent Crohn's Disease
por: Spinelli, Antonino, et al.
Publicado: (2012)

Laparoscopic surgery for complex and recurrent Crohn’s disease
por: Sevim, Yusuf, et al.
Publicado: (2017)

Strategies for Preventing Endoscopic Recurrence of Crohn's Disease 1 Year after Surgery: A Network Meta-Analysis
por: Feng, Jin-shan, et al.
Publicado: (2017)

Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen
por: Stallmach, Andreas, et al.
Publicado: (2022)

Crohn’s disease: a population-based study of surgery in the age of biological therapy
por: Stöss, Christian, et al.
Publicado: (2021)

Smoking Is Not an Independent Risk Factor for Surgery in Patients with Crohn’s Disease on Biologic Therapy
por: Halablab, Saleem M., et al.
Publicado: (2023)

Economic implications of biological therapy for Crohn's disease
por: Petryszyn, Paweł W., et al.
Publicado: (2015)

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
por: Gisbert, Javier P., et al.
Publicado: (2023)

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
por: Stallhofer, Johannes, et al.
Publicado: (2022)

Biologic therapies for Crohn’s disease: optimising the old and maximising the new
por: Samaan, Mark, et al.
Publicado: (2019)

The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence
por: Ingallinella, S., et al.
Publicado: (2020)

Biologics in Paediatric Crohn's Disease
por: Gouldthorpe, Oliver, et al.
Publicado: (2011)

Dual Biologic Therapy in an Adolescent With Camurati-Engelmann Disease and Crohn Disease
por: Sami, Ahmad Salah, et al.
Publicado: (2022)

Risk factors for recurrence after bowel resection for Crohn’s disease
por: Chen, Ze-Xian, et al.
Publicado: (2019)

The Role of Inflammation in Crohn's Disease Recurrence after Surgical Treatment
por: Sensi, B., et al.
Publicado: (2020)

Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery
por: Schnitzler, Fabian, et al.
Publicado: (2020)

Pathophysiology of Crohn’s disease inflammation and recurrence
por: Petagna, L., et al.
Publicado: (2020)

Post-operative prevention and monitoring of Crohn’s disease recurrence
por: Lee, Kate E, et al.
Publicado: (2022)

Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn's Disease
por: Liu, Eddie Y., et al.
Publicado: (2017)

Biologic therapy for Crohn’s disease over the last 3 decades
por: Shen, Ji-Liang, et al.
Publicado: (2022)

Laparoscopic redo surgery in recurrent ileocolic Crohn's disease: A standardised technique
por: Celentano, Valerio
Publicado: (2020)

Clinical and Endoscopic Recurrence after Surgical Resection in Patients with Crohn's Disease
por: Lee, Yang Woon, et al.
Publicado: (2014)

Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study
por: Kotze, Paulo Gustavo, et al.
Publicado: (2015)

Risk Factors for Postoperative Recurrence of Crohn’s Disease
por: Khoshkish, Shayan, et al.
Publicado: (2012)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease
por: Yu, Boran, et al.
Publicado: (2022)

Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
por: Szymanska, Edyta, et al.
Publicado: (2015)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn's Disease
por: Huang, He, et al.
Publicado: (2018)

PTPN2 Gene Variants Are Associated with Susceptibility to Both Crohn's Disease and Ulcerative Colitis Supporting a Common Genetic Disease Background
por: Glas, Jürgen, et al.
Publicado: (2012)

Surgery for bilateral vocal fold paralysis: Systematic review and meta-analysis
por: Titulaer, Kai, et al.
Publicado: (2022)

Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn’s disease: A systematic review and meta-analysis
por: Zhang, Lei, et al.
Publicado: (2023)

Ultrasonographic detection and assessment of the severity of Crohn's disease recurrence after ileal resection
por: Pallotta, Nadia, et al.
Publicado: (2010)

Surgical Strategies to Reduce Postoperative Recurrence of Crohn's Disease After Ileocolic Resection
por: Reynolds, Ian S., et al.
Publicado: (2021)

The Sasaki-W anastomosis for recurrent Crohn’s disease stenosis after the Kono-S anastomosis
por: Asai, Takahiro, et al.
Publicado: (2023)

Non-invasive Serological Monitoring for Crohn’s Disease Postoperative Recurrence
por: Hamilton, Amy L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jton9bkoheu16r1u2u2bj04fph